• ABC transporter (ABC = Adenosine triphosphate-Binding Cassette)
  • ABC transporter and cholestasis
  • ABC transporter mutation or ABC transporter polymorphism (ABC = Adenosine triphosphate-Binding Cassette)
• aberrant homing of lymphocytes
  • aberrant homing or gut homing or lymphocyte recruitment or lymphocyte homing and primary sclerosing cholangitis
• acne
  • acne and inflammatory bowel disease
• adhesion molecule
  • adhesion molecule and sclerosing cholangitis
• Addison's disease
• adverse effects
  • adverse effects and 5-aminosalicylate
  • adverse effects and azathioprine
  • adverse effects and ERCP
  • adverse effects and infliximab
  • adverse effects and 6-mercaptopurine
  • adverse effects and prednisone
  • adverse effects and rifampin
  • adverse effects and sulfasalazine
  • adverse effects and ursodeoxycholic acid
• AGR2 or AGR3
  • AGR2 or AGR3 and inflammatory bowel disease
• alanine aminotransferase (ALT)
• alanine aminotransferase and aspartate aminotransferase (ALT and AST)
• albumin
• Alagille syndrome
• alkaline phosphatase (ALP)
  • intestinal alkaline phosphatase
    • intestinal alkaline phosphatase and lipopolysaccharide
• allergic
• allopurinol
• alopecia
• alpha4beta7 integrin
• 5-aminosalicylic acid (5-ASA)
• ancestral haplotype
  • 8.1 ancestral haplotype
• ankylosing spondylitis
• animal model
  • animal model and autoimmune cholangitis
  • animal model and inflammatory bowel disease
  • animal model and primary biliary cirrhosis
  • animal model and sclerosing cholangitis
• antimitochondrial or anti-mitochondrial
  • antimitochondrial antibodies or anti-mitochondrial antibodies
• antineutrophil or anti-neutrophil
  • antineutrophil cytoplasmic antibodies or anti-neutrophil cytoplasmic antibodies
• antioxidant
• APECED (autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy)
• antiphospholipid syndrome (APS)
• apoptosis
• appendectomy
• arthritis
• artificial liver
• aryl hydrocarbon receptor
• ASCA (anti-Saccharomyces cerevisiae antibody)
  • ASCA and Crohn's disease
• ascites
• Ashkenazi
  • Ashkenazi and inflammatory bowel disease
• aspartate aminotransferase (AST)
• asplenia
• asymptomatic PBC
• asymptomatic PSC
• ATG16L1
  • ATG16L1 and Crohn's disease
• autism
• autoimmune cholangitis (AIC)
• autoimmune disease
• autoimmune hepatitis (AIH)
  • autoimmune hepatitis and sclerosing cholangitis
• autoimmune pancreatitis (AIP)
  • autoimmune pancreatitis and carbonic anhydrase
  • autoimmune pancreatitis and sclerosing cholangitis
• autoimmune polyglandular syndrome
• autoimmune regulator (AIRE)
• autoimmune sclerosing cholangitis (ASC)
• autophagy
  • autophagy and Crohn's disease
• azathioprine
• bactericidal/permeability-increasing protein (BPI)
  • BPI and cystic fibrosis
  • BPI and lipopolysaccharide
  • BPI and primary sclerosing cholangitis
• balsalazide (or colazal)
• Behcet's disease
• betaine
• bile acid synthesis
• bile metabolism
• bile transport
• biliary atresia
• biliary stricture
• biliary transport
• bilirubin
• bone disease
• breast cancer
• brush cytology
• BSEP (bile salt export pump)
  • BSEP or ABCB11 and cholestasis
  • BSEP or ABCB11 and sclerosing cholangitis
• BTNL2
  • BTNL2 and ulcerative colitis
• Budd-Chiari syndrome
• budesonide
• bupropion
• Candida
  • Candida and primary sclerosing cholangitis
• cancer prevention
• cancer surveillance
• capsule endoscopy
• CA19-9 (carbohydrate antigen 19-9)
  • CA19-9 and cholangiocarcinoma
  • CA19-9 and primary sclerosing cholangitis
• caspase
• catalase antibodies
• CCR5 (CC-chemokine receptor 5)
• CCR6 (CC-chemokine receptor 6)
• CCR9 (CC-chemokine receptor 9)
• CD40
• celiac disease
• chemoprevention or chemoprophylaxis
  • chemoprevention or chemoprophylaxis and 5-aminosalycilic acid
  • chemoprevention or chemoprophylaxis and ursodeoxycholic acid
• Child-Pugh
• chimerism
• Chlamydia
• cholangiocarcinoma (CCA)
  • cholangiocarcinoma and primary sclerosing cholangitis
  • cholangiocarcinoma and ursodeoxycholic acid
• cholangiocyte
• cholestasis
• cholesterol
• cholestyramine
• Clostridium
• colon cancer or colorectal carcinoma
  • colon cancer or colorectal carcinoma and 5-aminosalycilic acid
  • colon cancer or colorectal carcinoma and folate
  • colon cancer or colorectal carcinoma and omega-3
  • colon cancer or colorectal carcinoma and ursodeoxycholic acid
• colonoscopy
• complement C1
• complement C3
• complement C4
• complement C5
• constitutive androstane receptor (CAR)
• corticosteroid
• C-reactive protein
• CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly and telangiectasia)
• Crohn's disease
  • Crohn's disease and 5-aminosalicylate
  • Crohn's disease and 6-MP
  • Crohn's disease and azathioprine
  • Crohn's disease and corticosteroid
  • Crohn's disease and genetics
  • Crohn's disease and PSC
  • Crohn's disease and susceptibility gene
  • Crohn's disease and tumor necrosis factor
• Cryptosporidium
  • Cryptosporidium and sclerosing cholangitis
• CTLA-4 or cytotoxic T lymphocyte antigen-4
• Cushing's syndrome
• cycline
• cyclooxygenase
• cystic fibrosis or CFTR (CFTR = cystic fibrosis transmembrane conductance regulator)
  • CFTR and sclerosing cholangitis
  • cystic fibrosis and sclerosing cholangitis
• cytomegalovirus (CMV)
• common variable immunodeficiency (CVID)
  • CVID and sclerosing cholangitis
• cytochrome P450
  • CYP3A4
    • CYP3A4 and lithocholate
• cytoplasmic antibodies
• danazol
• defensin
• dehydrogenase antibodies
• depression
• deoxycholate
• diabetes
• diet
• DLG5
• DNL1 or DNASE1
• docosahexaenoic acid (DHA)
• drug-induced hepatitis
• dysplasia
• ECM1
• edema
• eicosapentaenoic acid (EPA)
• embolism
• encephalopathy
  • hepatic encephalopathy
• endotoxin
• enolase antibodies
• environmental influence
• eosinophil
  • eosinophil and sclerosing cholangitis
• epidemiology
• epithelial barrier
• Epstein-Barr
• ERCP (endoscopic retrograde cholangiopancreatography)
• erythrocyte sedimentation
• esophageal varices
• estrogen
• etanercept (Enbrel)
• factor V Leiden
• familial
  • familial and inflammatory bowel disease
• farnesoid X receptor (FXR)
• FASL or TNFSF6
• fatigue
• FCGR3A
• fetoprotein [as in alpha-fetoprotein]
• fibrate
  • fibrate (or bezafibrate) and primary biliary cirrhosis
  • fibrate (or bezafibrate) and primary sclerosing cholangitis
• fish oil or omega-3 or n-3 PUFA (PUFA = polyunsaturated fatty acid)
  • fish oil or omega-3 or n-3 PUFA and inflammatory bowel disease
  • fish oil or omega-3 or n-3 PUFA and parenteral nutrition
• focal hepatic lesion
• folate
• FOXA2
  • FOXA2 and bile
• FOXP3
• gall bladder
• gall stone
• gender difference
  • gender and docosahexaenoic acid
  • gender and primary sclerosing cholangitis
  • gender (or sexual dimorphic) and retinoid X receptor
• gene expression
• gene therapy
• Gilbert's syndrome
• glucocorticoid receptor (GR)
• glutamyl transpeptidase (GGT)
• gp210
• Graves disease
• glutathione
• haptoglobin
  • haptoglobin and primary sclerosing cholangitis
• Hashimoto's thyroiditis
• hearing loss
• heat shock protein
• Helicobacter
  • Helicobacter and sclerosing cholangitis
• hemochromatosis
• hepatic copper
• hepatic iron
• hepatic transport
• hepatitis B vaccine
• hepatocellular carcinoma (HCC)
• hepatocyte nuclear factor
• HNF4A (or hepatocyte nuclear factor 4alpha)
• hepatotoxicity
• hepcidin
• herb
  • herb and hepatotoxicity
• hereditary
  • hereditary and inflammatory bowel disease
• herpes
• high-dose ursodeoxycholic acid
• histiocytosis
  • histiocytosis X
  • Langerhans cell histiocytosis
  • Langerhans cell histiocytosis and sclerosing cholangitis
• HIV and sclerosing cholangitis
• HLA-A (HLA = human leukocyte antigen)
• HLA-B (HLA = human leukocyte antigen)
  • HLA-B and ankylosing spondylitis
  • HLA-B and primary sclerosing cholangitis
  • HLA-B and ulcerative colitis
• HLA-C (HLA = human leukocyte antigen)
  • HLA-C and primary sclerosing cholangitis
  • HLA-C and psoriasis
• HLA-DP (HLA = human leukocyte antigen)
• HLA-DQ (HLA = human leukocyte antigen)
  • HLA-DQ and celiac disease
    • HLA-DQ2 and celiac disease
    • HLA-DQ8 and celiac disease
  • HLA-DQ and primary sclerosing cholangitis
• HLA-DR (HLA = human leukocyte antigen)
  • HLA-DR and Crohn's disease
  • HLA-DR and multiple sclerosis
  • HLA-DR and primary biliary cirrhosis
  • HLA-DR and primary sclerosing cholangitis
  • HLA-DR and rheumatoid arthritis
  • HLA-DR and ulcerative colitis
    • HLA-DRB1
      • HLA-DRB1 and Crohn's disease
      • HLA-DRB1 and multiple sclerosis
      • HLA-DRB1 and primary biliary cirrhosis
      • HLA-DRB1 and primary sclerosing cholangitis
      • HLA-DRB1 and rheumatoid arthritis
      • HLA-DRB1 and ulcerative colitis
• homocysteine
• HMGB1
• hygiene hypothesis
• hyperbilirubinemia
• hyper-IgM syndrome
  • hyper-IgM syndrome and sclerosing cholangitis
• hyposplenism or asplenia
• ICAM-1 (intercellular adhesion molecule-1)
• ichthyosis
• IgA (immunoglobulin A)
• IgA deficiency
  • IgA deficiency and sclerosing cholangitis
• IgG4
• immunization
• immunogenetics
• immunosuppression
• infectious agent
• inflammatory bowel disease (IBD)
  • IBD and 5-aminosalicylate
  • IBD and 6-MP
  • IBD and azathioprine
  • IBD and corticosteroid
  • IBD and extraintestinal manifestation
  • IBD and genetics
  • IBD and PSC
  • IBD and susceptibility gene
  • IBD and tumor necrosis factor
• infliximab
• interleukin
  • IL-6 or interleukin-6
    • IL-6 and Crohn's disease
    • IL-6 and inflammatory bowel disease
    • IL-6 and ulcerative colitis
  • IL-7 or interleukin-7
  • IL-10 or interleukin-10
  • IL-12 or interleukin-12
  • IL-13 or interleukin-13
  • IL-15 or interleukin-15
  • IL-17 or interleukin-17
    • IL-17 and Crohn's disease
    • IL-17 and inflammatory bowel disease
    • IL-17 and ulcerative colitis
  • IL-18 or interleukin-18
  • IL-21 or interleukin-21
  • IL-22 or interleukin-22
  • IL-23 or interleukin-23
    • IL-23 and Crohn's disease
    • IL-23 and inflammatory bowel disease
    • IL-23 and ulcerative colitis
  • IL-23R or interleukin-23 receptor
    • IL-23R and inflammatory bowel disease
    • IL-23R and psoriasis
    • IL-23R and psoriatic arthritis
  • IL-27 or interleukin-27
• intestinal permeability or leaky gut
  • intestinal permeability or leaky gut or permeable colon and primary sclerosing cholangitis
• IPEX
• IRGM
• IRF5 (interferon regulatory factor 5)
• iron overload or hemochromatosis
• isotretinoin or accutane
  • isotretinoin and inflammatory bowel disease
• lactoferrin
• lactoferrin antibodies
• lipopolysaccharide (LPS; endotoxin)
• lithocholate (lithocholic acid)
• liver biopsy
• liver function test (LFT)
• liver transplant
• living donor
• LKM antibody (LKM = liver/kidney microsome)
• lupus
• liver X receptor (LXR)
• lymphoid hyperplasia
• lymphoplasmacytic sclerosing cholangitis
• magnetic resonance imaging (MRI)
• MAGI2
• major histocompatibility complex (MHC)
• mannose binding lectin (MBL)
• Molecular Adsorbent Recirculating System (MARS)
• mast cell
• Mayo risk score
• MDR or MRP (multidrug resistance protein)
  • MDR1 or ABCB1 and ulcerative colitis
  • MDR3 or ABCB4 and cholestasis
  • MDR3 or ABCB4 and sclerosing cholangitis
• measles
• meningitis
• MELD or PELD (model for end-stage liver disease or pediatric end-stage liver disease)
• 6-mercaptopurine (6-MP)
• mesalazine or mesalamine
• metal stent
• metalloproteinase
• methionine
• methotrexate
• MHC2TA or CIITA
• microchimerism
• microsomal antibodies
• milk thistle
• miscarriage or abortion
• mitochondrial antibodies
• molecular mimicry
• monosomy
• MRCP (magnetic resonance cholangiopancreatography)
• mucin
• multiple sclerosis (MS)
• MST1 or macrophage stimulating
  • MST1 or macrophage stimulating and inflammatory bowel disease
  • MST1 or macrophage stimulating and primary sclerosing cholangitis
• muscle cramp
• myasthenia gravis or thymoma
• Mycobacterium
  • Mycobacterium and Crohn's disease
• mycophenolate
• myelin basic protein
• myosin
• naltrexone
• nanobacteria
• neonatal cholestasis
• neonatal sclerosing cholangitis
• nonalcoholic steatohepatitis (NASH)
• NCF4
• neoplasia
• nephritis
• neuropathy
• nitric oxide
• norursodeoxycholic acid
• NF-kappaB (nuclear factor-kappaB)
• NFKBIA (nuclear factor-kappaB inhibitor of activation)
• NOD1 or CARD4 (CARD4 = caspase recruitment domain 4)
• NOD2 or CARD15 (CARD15 = caspase recruitment domain 15)
• NRAMP1 (natural resistance-associated macrophage protein 1)
• nuclear antibodies
• nutrition or diet
• organic anion transport
• organic cation transport
• osteoblast
• osteoclast
• osteopontin
• osteoporosis
• overlap syndrome
• oxidative stress
• p-ANCA (perinuclear antineutrophil cytoplasmic antibodies)
  • p-ANCA and inflammatory bowel disease
  • p-ANCA and primary sclerosing cholangitis
  • p-ANCA and ulcerative colitis
  • p-ANCA and vasculitis
• pancolitis
• pancreatitis
  • pancreatitis and ERCP
  • pancreatitis and genetics
• parasitic worm or Helminth
• PDCD1 or PD-1
• PDZK1
  • PDZK1 and primary sclerosing cholangitis
• peptidylarginine deiminase (PAD)
• peroxidase antibodies
• peroxisome proliferator-activated receptor (PPAR)
  • PPARalpha
  • PPARbeta
  • PPARdelta
  • PPARgamma
    • PPARgamma and CFTR
    • PPARgamma and colon cancer
    • PPARgamma and inflammatory bowel disease
• phospholipid
• platelet
• polymorphism
• portal hypertension
• post-ERCP pancreatitis
• pouchitis
• prednisone
• pregnancy
  • pregnancy and primary sclerosing cholangitis
• pregnane X receptor (PXR; also known as steroid and xenobiotic receptor (SXR))
  • PXR (or SXR) and ulcerative colitis
  • PXR (or SXR) and sclerosing cholangitis
• primary biliary cirrhosis (PBC)
• primary sclerosing cholangitis (PSC)
  • PSC and Crohn's disease
  • PSC and celiac disease
  • PSC and children
  • PSC and genetics
  • PSC and pruritus
  • PSC and susceptibility gene
  • PSC and ulcerative colitis
  • PSC and ursodeoxycholic acid
• probiotic
• progressive familial intrahepatic cholestasis (PFIC)
• pruritus
• psoriasis
• psoriatic arthritis
• PRSS1
• PSTI or SPINK1
• PTGER4
• PTPN2
• PTPN22
• PTPRC or CD45
• pulmonary hypertension
• reactive oxygen
• recurrence of PBC
• recurrence of PSC
• Remicade
• resolvin
• retinoic acid
  • retinoic acid and tight junction or retinoic acid and epithelial integrity
  • retinoic acid and IgA
  • retinoic acid and lymphocyte homing
  • retinoic acid and colitis
  • retinoic acid and Th17
• retinoic acid receptor (RAR)
• retinoid X receptor (RXR)
  • retinoid X receptor alpha (RXRA)
  • retinoid X receptor beta (RXRB)
  • retinoid X receptor gamma (RXRG)
  • retinoid X receptor and cholestasis
  • retinoid X receptor and colon cancer
  • retinoid X receptor and docosahexaenoic acid
  • retinoid X receptor and lipopolysaccharide
  • retinoid X receptor and vasculitis
  • retinoid X receptor and Wegener's granulomatotosis
• retrovirus
• rheumatoid arthritis
• rifampicin or rifampin
  • rifampin (or rifampicin) and PXR
• rituximab
• RUNX (runt-related)
  • RUNX1
    • RUNX1 and autoimmune disease
    • RUNX1 and regulatory T cell
    • RUNX1 and Treg
  • RUNX2
  • RUNX3
    • RUNX3 and cholangiocarcinoma
    • RUNX3 and colon cancer
    • RUNX3 and inflammatory bowel disease or colitis
• sacroiliitis
• S-adenosyl-L-methionine (SAMe)
• sarcoidosis
• sclerosing cholangitis
• segmented filamentous bacteria
• secondary sclerosing cholangitis
• selenium
• serum lipid
• shared epitope
• short chain fatty acid
• silymarin or silibinin
• sinusitis
• Sjogren's syndrome
  • Sjogren's syndrome and primary biliary cirrhosis
  • Sjogren's syndrome and primary sclerosing cholangitis
• small duct PSC
• smoking or tobacco or nicotine
  • smoking or tobacco or nicotine and inflammatory bowel disease
  • smoking or tobacco or nicotine and primary sclerosing cholangitis
• smooth muscle antibodies
• suppressor of cytokine signaling (SOCS)
• solute carrier (SLC)
• splenomegaly
• spondyloarthropathies
• STAT1
• STAT2
• STAT3
• STAT4
• STAT5
• STAT6
• stem cell transplant
• sulfapyridine
• sulfasalazine
• sulfide or sulphide
• sulindac
• superantigen
• susceptibility gene
• systemic lupus erythematosus
• systemic sclerosis
• T-bet
• TGR5 or GPBAR1
• T lymphocyte
  • Th1
  • Th2
  • Th17
    • Th17 and autoimmune disease
    • Th17 and inflammatory bowel disease
    • Th17 and multipe sclerosis
    • Th17 and psoriasis
    • Th17 and psoriatic arthritis
    • Th17 and rheumatoid arthritis
    • Th17 and Sjogen's syndrome
    • Th17 and uveitis
  • Treg or regulatory T cell
• tacrolimus
• Tangier disease
• 6-thioguanine (6-TG)
• thrombocytopenia
• thyroid
• tight junction
• tissue inhibitor of metalloproteinase (TIMP)
• Toll-like receptor (TLR)
• toxoplasmosis
• toxic bile
• transjugular intrahepatic portosystemic shunt (TIPS)
• transforming growth factor (TGF)
• transglutaminase
• trichloroethylene
• tropomyosin
• Trypanosoma
• tumor necrosis factor (TNF)
  • tumor necrosis factor and inflammatory bowel disease
  • tumor necrosis factor and primary sclerosing cholangitis
• TNFSF15
• twins
• ulcerative colitis (UC)
  • UC and 5-aminosalicylate
  • UC and 6-MP
  • UC and azathioprine
  • UC and corticosteroid
  • UC and genetics
  • UC and PSC
  • UC and susceptibility gene
  • UC and tumor necrosis factor
• ursodeoxycholic acid (urso; UDCA; ursodiol)
• uveitis
• vaccination
• vancomycin
  • vancomycin and primary sclerosing cholangitis
• vasculitis
• veno-occlusive disease (VOD)
• vitamin A
• vitamin B
• vitamin C
• vitamin D
• vitamin D receptor (VDR)
  • VDR and bone disease
  • VDR and colon cancer
  • VDR and Crohn's disease
  • VDR and inflammatory bowel disease
  • VDR and ulcerative colitis
• vitamin deficiency
  • vitamin deficiency and Crohn's disease
  • vitamin deficiency and primary sclerosing cholangitis
  • vitamin deficiency and ulcerative colitis
• vitamin E
• vitamin K
• Watermelon stomach
• Wegener's granulomatosis
• Wilson's disease
• XBP1
• xenobiotic
• zonulin

  Scientific Literature By Author:

  
  
• Adams DH
• Angulo P
• Bergasa NV
• Bergquist A
• Boberg KM
• Bowlus CL
• Boyer JL
• Broome U
• Chapman R
• Cho JH
• Czaja AJ
• Das KM
• Donaldson PT
• Duerr R
• Eaden J
• Eksteen B
• Everson GT
• Fickert P
• Forman L
• Freedman SD
• Gershwin ME
• Gores GJ
• Hanauer SB
• Harnois DM
• Heathcote EJ
• Hirschfield GM
• Hofmann AF
• Holubar SD
• Hov JR
• Invernizzi P
• Jewell D
• Kam I
• Kaplan MM
• Karlsen TH
• Kim WR
• Klein R
• Kullak-Ublick GA
• LaRusso N
• Lashner B
• Lazaridis KN
• Leuschner U
• Levine J
• Levy C
• Lindor KD
• Ludwig J
• Marzioni M
• Mason AL
• Mieli-Vergani G
• Nielsen OH
• Neuberger J
• Neurath MF
• Olsson R
• Orth T
• Paumgartner G
• Ponsioen CY
• Portmann B
• Poupon R
• Rioux JD
• Rodes J
• Rodrigues CM
• Roozendaal C
• Rutgeerts P
• Sandborn WJ
• Satsangi J
• Schreiber S
• Schrumpf E
• Selmi C
• Serhan CN
• Sherlock S
• Sollid LM
• Stiehl A
• Strober W
• Trauner M
• Trotter JF
• Ullman T
• van Heel D
• Van Thiel D
• Vergani D
• Vierling JM
• Wadstrom T
• Wiesner RH

www psc-literature.org

PSC Partners Seeking a Cure (www.pscpartners.org)
Don and Ricky Safer
Ricky Safer e-mail: contactus@pscpartners.org